Investigation of maintenance of efficacy for 24 hours after teneligliptin administration, and the mechanism of action.
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000011312
- Lead Sponsor
- Hyogo college of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with type-1 diabetes; diabetes due to pancreatic disorder; or secondary diabetes, due to Cushings syndrome, acromegaly, etc. 2)Patients to whom the contraindications in the Package Insert apply. 3)Patients are classed as having excessive alcohol consumption if their mean daily intake of pure alcohol is 60 g or higher, this being equivalent to three cups of sake, one cup of shochu (a Japanese spirit), three medium-sized bottles of beer, three whiskey or brandy doubles, or five glasses of wine. 4)Patients who are or may be pregnant, or are breastfeeding. 5) Patients whose participation in the study is judged by the Investigator or Sub-Investigator to be inappropriate for any other reason.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Active GLP1 concentration Total and active GIP concentration Change in postprandial glucose( For 5 days) Change in HbA1c(For 3 months)
- Secondary Outcome Measures
Name Time Method